2011 - NANETS https://nanets.net/abstracts-archive/2011?format=html Thu, 15 Feb 2018 12:39:00 -0500 en-GB hourly 1 O02 – 68Ga-DOTATATE PET/CT Imaging for Advanced Neuroendocrine Carcinoma in the United States https://nanets.net/abstracts-archive/2011/149-o02-68ga-dotatate-pet-ct-imaging-for-advanced-neuroendocrine-carcinoma-in-the-united-states?format=html O02 – 68Ga-DOTATATE PET/CT Imaging for Advanced Neuroendocrine Carcinoma in the United States Eric H. Liu, Jeff Clanton, Dominique Delbeke, Martin Sandler, Bill Martin, Ronald C. Walker

]]> https://nanets.net/abstracts-archive/2011/149-o02-68ga-dotatate-pet-ct-imaging-for-advanced-neuroendocrine-carcinoma-in-the-united-states?format=html Eric H. Liu, Jeff Clanton, Dominique Delbeke, Martin Sandler, Bill Martin, Ronald C. Walker

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 12:39:00 -0500 O01 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome -- Update on the Current Status https://nanets.net/abstracts-archive/2011/148-o01-an-ongoing-double-blind-randomized-placebo-controlled-clinical-trial-investigating-the-efficacy-and-safety-of-somatuline-depot-lanreotide-injection-in-the-treatment-of-carcinoid-syndrome-update-on-the-current-status?format=html O01 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome -- Update on the Current Status Edda Gomez-Panzani, Stephen Chang, Nadine Knowles and Veronique Fohanno

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/148-o01-an-ongoing-double-blind-randomized-placebo-controlled-clinical-trial-investigating-the-efficacy-and-safety-of-somatuline-depot-lanreotide-injection-in-the-treatment-of-carcinoid-syndrome-update-on-the-current-status?format=html Edda Gomez-Panzani, Stephen Chang, Nadine Knowles and Veronique Fohanno

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 12:38:59 -0500 C29 – Correlation of Progression-Free Survival (PFS) with Early Response of Biomarkers Chromogranin A (CgA) and 5-Hhydroxyindoleacetic Acid (5-HIAA) Levels in Patients with Advanced Neuroendocrine Tumors: Phase III RADIANT-2 Study Results https://nanets.net/abstracts-archive/2011/146-c29-correlation-of-progression-free-survival-pfs-with-early-response-of-biomarkers-chromogranin-a-cga-and-5-hhydroxyindoleacetic-acid-5-hiaa-levels-in-patients-with-advanced-neuroendocrine-tumors-phase-iii-radiant-2-study-results?format=html C29 – Correlation of Progression-Free Survival (PFS) with Early Response of Biomarkers Chromogranin A (CgA) and 5-Hhydroxyindoleacetic Acid (5-HIAA) Levels in Patients with Advanced Neuroendocrine Tumors: Phase III RADIANT-2 Study Results Edward Wolin, Daniel Castellano, Gregory Kaltsas, David Gross, Ashok Panneerselvam, Judith Klimovsky, Stephen Saletan, James Yao, Eric Baudin

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/146-c29-correlation-of-progression-free-survival-pfs-with-early-response-of-biomarkers-chromogranin-a-cga-and-5-hhydroxyindoleacetic-acid-5-hiaa-levels-in-patients-with-advanced-neuroendocrine-tumors-phase-iii-radiant-2-study-results?format=html Edward Wolin, Daniel Castellano, Gregory Kaltsas, David Gross, Ashok Panneerselvam, Judith Klimovsky, Stephen Saletan, James Yao, Eric Baudin

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:18 -0500 C30 – Treatment of Small Bowel Neuroendocrine Tumors (NETS) in a Multidisciplinary Specialty Center Increases Survival https://nanets.net/abstracts-archive/2011/147-c30-treatment-of-small-bowel-neuroendocrine-tumors-nets-in-a-multidisciplinary-specialty-center-increases-survival?format=html C30 – Treatment of Small Bowel Neuroendocrine Tumors (NETS) in a Multidisciplinary Specialty Center Increases Survival Eugene A. Woltering, MD, Anne E. Diebold, BS, Yi-Zarn Wang, DDS, MD, Lowell B. Anthony, MD, John Philip Boudreaux, MD, Ann Porter Uhlhorn, RN, Pamela Ryan BSN, RN, Leigh Anne Kamerman-Burns, RD, LDN, Daniel J. Frey, MD, Daniel Raines, MD, Ryan N. Majoria, MD, Richard J. Campeau, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/147-c30-treatment-of-small-bowel-neuroendocrine-tumors-nets-in-a-multidisciplinary-specialty-center-increases-survival?format=html Eugene A. Woltering, MD, Anne E. Diebold, BS, Yi-Zarn Wang, DDS, MD, Lowell B. Anthony, MD, John Philip Boudreaux, MD, Ann Porter Uhlhorn, RN, Pamela Ryan BSN, RN, Leigh Anne Kamerman-Burns, RD, LDN, Daniel J. Frey, MD, Daniel Raines, MD, Ryan N. Majoria, MD, Richard J. Campeau, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:18 -0500 C28 – Cervical and Upper Mediastinal Lymph Node Metastasis from GI and Pancreatic Neuroendocrine Tumors: Incidence and Management https://nanets.net/abstracts-archive/2011/145-c28-cervical-and-upper-mediastinal-lymph-node-metastasis-from-gi-and-pancreatic-neuroendocrine-tumors-incidence-and-management?format=html C28 – Cervical and Upper Mediastinal Lymph Node Metastasis from GI and Pancreatic Neuroendocrine Tumors: Incidence and Management Yi-Zarn Wang DDS, MD, George Mayhall, Lowell Anthony MD, Richard Campeau MD, J. Philip Boudreaux MD, and Eugene Woltering MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/145-c28-cervical-and-upper-mediastinal-lymph-node-metastasis-from-gi-and-pancreatic-neuroendocrine-tumors-incidence-and-management?format=html Yi-Zarn Wang DDS, MD, George Mayhall, Lowell Anthony MD, Richard Campeau MD, J. Philip Boudreaux MD, and Eugene Woltering MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:17 -0500 C27 – Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well-Differentiated Pancreatic Neuroendocrine Tumor (NET) https://nanets.net/abstracts-archive/2011/144-c27-progression-free-survival-pfs-by-blinded-independent-central-review-bicr-and-updated-overall-survival-os-of-sunitinib-versus-placebo-for-patients-with-progressive-unresectable-well-differentiated-pancreatic-neuroendocrine-tumor-net?format=html C27 – Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well-Differentiated Pancreatic Neuroendocrine Tumor (NET) Aaron Vinik, Eric Van Cutsem, Patricia Niccoli, Jean-Luc Raoul, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Juan W. Valle, Peter Metrakos, Denis Smith, Jen-Shi Chen, Dieter Hörsch, Daniel E. Castellano, Hagen F. Kennecke, Joel Picus, Guy Van Hazel, Shem Patyna, Dongrui Ray Lu, Richard C. Chao, Eric Raymond

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/144-c27-progression-free-survival-pfs-by-blinded-independent-central-review-bicr-and-updated-overall-survival-os-of-sunitinib-versus-placebo-for-patients-with-progressive-unresectable-well-differentiated-pancreatic-neuroendocrine-tumor-net?format=html Aaron Vinik, Eric Van Cutsem, Patricia Niccoli, Jean-Luc Raoul, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Juan W. Valle, Peter Metrakos, Denis Smith, Jen-Shi Chen, Dieter Hörsch, Daniel E. Castellano, Hagen F. Kennecke, Joel Picus, Guy Van Hazel, Shem Patyna, Dongrui Ray Lu, Richard C. Chao, Eric Raymond

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:16 -0500 C26 – Comparison of 68Ga-somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma https://nanets.net/abstracts-archive/2011/143-c26-comparison-of-68ga-somatostatin-analogues-18f-dopa-and-18f-fdg-pet-ct-in-patients-with-recurrent-medullary-thyroid-carcinoma?format=html C26 – Comparison of 68Ga-somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Diana Salvo; Stefano Fanti; Alessandro Giordano; Vittoria Rufini

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/143-c26-comparison-of-68ga-somatostatin-analogues-18f-dopa-and-18f-fdg-pet-ct-in-patients-with-recurrent-medullary-thyroid-carcinoma?format=html Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Diana Salvo; Stefano Fanti; Alessandro Giordano; Vittoria Rufini

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:15 -0500 C25 – Multi-Feature Method for Ascertaining NET Cases in a Clinical Data Warehouse https://nanets.net/abstracts-archive/2011/142-c25-multi-feature-method-for-ascertaining-net-cases-in-a-clinical-data-warehouse?format=html C25 – Multi-Feature Method for Ascertaining NET Cases in a Clinical Data Warehouse Marie Synnestvedt PhD, Bonnie Bennett RN, BSN, Hillary Faust MD, Mark Weiner MD, David C. Metz MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/142-c25-multi-feature-method-for-ascertaining-net-cases-in-a-clinical-data-warehouse?format=html Marie Synnestvedt PhD, Bonnie Bennett RN, BSN, Hillary Faust MD, Mark Weiner MD, David C. Metz MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:14 -0500 C23 – Neuroendocrine Tumor Collaborative Registry https://nanets.net/abstracts-archive/2011/140-c23-neuroendocrine-tumor-collaborative-registry?format=html C23 – Neuroendocrine Tumor Collaborative Registry Oleg Shats, Jean F. Botha, Jean Grem, Lucienne Case, Alexander Sherman, Janmin Feng, Greg Wilson, Simon Sherman

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/140-c23-neuroendocrine-tumor-collaborative-registry?format=html Oleg Shats, Jean F. Botha, Jean Grem, Lucienne Case, Alexander Sherman, Janmin Feng, Greg Wilson, Simon Sherman

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:13 -0500 C24 – RADIANT-2: A Randomized, Double-Blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR vs Placebo + Octreotide LAR in Patients with Advanced Neuroendocrine Tumors: Progression-Free Survival by Primary Tumor Site and Updated Safety Result https://nanets.net/abstracts-archive/2011/141-c24-radiant-2-a-randomized-double-blind-multicenter-phase-iii-trial-of-everolimus-octreotide-lar-vs-placebo-octreotide-lar-in-patients-with-advanced-neuroendocrine-tumors-progression-free-survival-by-primary-tumor-site-and-updated-safety-results?format=html C24 – RADIANT-2: A Randomized, Double-Blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR vs Placebo + Octreotide LAR in Patients with Advanced Neuroendocrine Tumors: Progression-Free Survival by Primary Tumor Site and Updated Safety Result Jonathan Strosberg, Sergio Ricci, Philippe Ruszniewski, Paola Tomassetti, Valentine Jehl, Stephen Saletan, Marianne Pavel, James Yao

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/141-c24-radiant-2-a-randomized-double-blind-multicenter-phase-iii-trial-of-everolimus-octreotide-lar-vs-placebo-octreotide-lar-in-patients-with-advanced-neuroendocrine-tumors-progression-free-survival-by-primary-tumor-site-and-updated-safety-results?format=html Jonathan Strosberg, Sergio Ricci, Philippe Ruszniewski, Paola Tomassetti, Valentine Jehl, Stephen Saletan, Marianne Pavel, James Yao

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:13 -0500 C22 – Generator Produced 68Ga for Clinical Preparations of [68Ga]DOTATOC for Imaging Neuroendocrine Tumor Patients: Initial Studies at the University of Iowa https://nanets.net/abstracts-archive/2011/139-c22-generator-produced-68ga-for-clinical-preparations-of-68ga-dotatoc-for-imaging-neuroendocrine-tumor-patients-initial-studies-at-the-university-of-iowa?format=html C22 – Generator Produced 68Ga for Clinical Preparations of [68Ga]DOTATOC for Imaging Neuroendocrine Tumor Patients: Initial Studies at the University of Iowa Michael K. Schultz; Yusuf Menda; Thomas O'Dorisio; Laura L. Boles Ponto; Kathy Thedes-Reynolds; John J. Sunderland; David L. Bushnell; G. Leonard Watkins; M. Sue O'Dorisio

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/139-c22-generator-produced-68ga-for-clinical-preparations-of-68ga-dotatoc-for-imaging-neuroendocrine-tumor-patients-initial-studies-at-the-university-of-iowa?format=html Michael K. Schultz; Yusuf Menda; Thomas O'Dorisio; Laura L. Boles Ponto; Kathy Thedes-Reynolds; John J. Sunderland; David L. Bushnell; G. Leonard Watkins; M. Sue O'Dorisio

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:12 -0500 C21 – Telotristat Etiprate Produces Clinical and Biochemical Responses in Patients with Symptomatic Carcinoid Syndrome: Preliminary Results of an Ongoing Phase 2, Multicenter, Open-Label, Serial-Ascending, European Study https://nanets.net/abstracts-archive/2011/138-c21-telotristat-etiprate-produces-clinical-and-biochemical-responses-in-patients-with-symptomatic-carcinoid-syndrome-preliminary-results-of-an-ongoing-phase-2-multicenter-open-label-serial-ascending-european-study?format=html C21 – Telotristat Etiprate Produces Clinical and Biochemical Responses in Patients with Symptomatic Carcinoid Syndrome: Preliminary Results of an Ongoing Phase 2, Multicenter, Open-Label, Serial-Ascending, European Study Marianne Pavel, Bertram Wiedenmann, Thomas Seufferlein, Joel Freiman, Linda Law, Phillip Banks, Kenny Frazier, Jessica Jackson, Brian Zambrowicz

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/138-c21-telotristat-etiprate-produces-clinical-and-biochemical-responses-in-patients-with-symptomatic-carcinoid-syndrome-preliminary-results-of-an-ongoing-phase-2-multicenter-open-label-serial-ascending-european-study?format=html Marianne Pavel, Bertram Wiedenmann, Thomas Seufferlein, Joel Freiman, Linda Law, Phillip Banks, Kenny Frazier, Jessica Jackson, Brian Zambrowicz

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:11 -0500 C20 – Pattern and Clinical Predictors of Lymph Node Involvement in Neuroendocrine Neoplasms of the Pancreas https://nanets.net/abstracts-archive/2011/137-c20-pattern-and-clinical-predictors-of-lymph-node-involvement-in-neuroendocrine-neoplasms-of-the-pancreas?format=html C20 – Pattern and Clinical Predictors of Lymph Node Involvement in Neuroendocrine Neoplasms of the Pancreas Stefano Partelli, Rim Cherif, Letizia Boninsegna, Sebastien Gaujoux, Stefano Crippa, Anne Couvelard, Aldo Scarpa, Alain Sauvanet, Philippe Ruszniewski

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/137-c20-pattern-and-clinical-predictors-of-lymph-node-involvement-in-neuroendocrine-neoplasms-of-the-pancreas?format=html Stefano Partelli, Rim Cherif, Letizia Boninsegna, Sebastien Gaujoux, Stefano Crippa, Anne Couvelard, Aldo Scarpa, Alain Sauvanet, Philippe Ruszniewski

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:10 -0500 C19 – Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Low Grade Neuroendocrine Tumors (mNETs) https://nanets.net/abstracts-archive/2011/136-c19-outcomes-of-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-metastatic-low-grade-neuroendocrine-tumors-mnets?format=html C19 – Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Low Grade Neuroendocrine Tumors (mNETs) Boris G. Naraev MD, PhD, Nancy Sharma, MD, Eric S. Engelman, DO, David L. Bushnell, Jr., MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/136-c19-outcomes-of-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-metastatic-low-grade-neuroendocrine-tumors-mnets?format=html Boris G. Naraev MD, PhD, Nancy Sharma, MD, Eric S. Engelman, DO, David L. Bushnell, Jr., MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:09 -0500 C17 – Reproducibility of [68Ga]DOTATOC Imaging in Neuroendocrine Tumors https://nanets.net/abstracts-archive/2011/134-c17-reproducibility-of-68ga-dotatoc-imaging-in-neuroendocrine-tumors?format=html C17 – Reproducibility of [68Ga]DOTATOC Imaging in Neuroendocrine Tumors Yusuf Menda, MD, Laura L. Boles Ponto, PhD, Thomas O'Dorisio, MD, Michael K. Schultz, PhD, G. Leonard Watkins, PhD, John Sunderland, PhD, Michael Graham, MD PhD, David Bushnell, MD, M. Sue O'Dorisio, MD, PhD

]]> https://nanets.net/abstracts-archive/2011/134-c17-reproducibility-of-68ga-dotatoc-imaging-in-neuroendocrine-tumors?format=html Yusuf Menda, MD, Laura L. Boles Ponto, PhD, Thomas O'Dorisio, MD, Michael K. Schultz, PhD, G. Leonard Watkins, PhD, John Sunderland, PhD, Michael Graham, MD PhD, David Bushnell, MD, M. Sue O'Dorisio, MD, PhD

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:08 -0500 C18 – High Grade Neuroendocrine Carcinoma of the Uterine Cervix: Outcomes and the Role of Radiation and Chemotherapy -- The University of Iowa Experience https://nanets.net/abstracts-archive/2011/135-c18-high-grade-neuroendocrine-carcinoma-of-the-uterine-cervix-outcomes-and-the-role-of-radiation-and-chemotherapy-the-university-of-iowa-experience?format=html C18 – High Grade Neuroendocrine Carcinoma of the Uterine Cervix: Outcomes and the Role of Radiation and Chemotherapy -- The University of Iowa Experience Boris G. Naraev, MD, PhD, Nancy Sharma, MD, Michael J. Goodheart, MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/135-c18-high-grade-neuroendocrine-carcinoma-of-the-uterine-cervix-outcomes-and-the-role-of-radiation-and-chemotherapy-the-university-of-iowa-experience?format=html Boris G. Naraev, MD, PhD, Nancy Sharma, MD, Michael J. Goodheart, MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:08 -0500 C16 – Single Dose Prophylactic Octreotide Does Not Prevent Intraoperative Carcinoid Crisis https://nanets.net/abstracts-archive/2011/133-c16-single-dose-prophylactic-octreotide-does-not-prevent-intraoperative-carcinoid-crisis?format=html C16 – Single Dose Prophylactic Octreotide Does Not Prevent Intraoperative Carcinoid Crisis Kristen P. Massimino, Ola Harrskog, SuEllen J. Pommier, Rodney F. Pommier

]]> https://nanets.net/abstracts-archive/2011/133-c16-single-dose-prophylactic-octreotide-does-not-prevent-intraoperative-carcinoid-crisis?format=html Kristen P. Massimino, Ola Harrskog, SuEllen J. Pommier, Rodney F. Pommier

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:07 -0500 C15 – Resection of At-Risk Mesenteric Lymph Nodes Improves the Outcome of Patients with Small Bowel Neuroendocrine Tumors https://nanets.net/abstracts-archive/2011/132-c15-resection-of-at-risk-mesenteric-lymph-nodes-improves-the-outcome-of-patients-with-small-bowel-neuroendocrine-tumors?format=html C15 – Resection of At-Risk Mesenteric Lymph Nodes Improves the Outcome of Patients with Small Bowel Neuroendocrine Tumors Christine S. Landry MD, Heather Y. Lin PhD, Alexandria Phan MD, Chusilp Charnsangavej MD, Eddie K. Abdalla MD, J. Nicolas Vauthey MD, James C. Yao MD, Jason B. Fleming MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/132-c15-resection-of-at-risk-mesenteric-lymph-nodes-improves-the-outcome-of-patients-with-small-bowel-neuroendocrine-tumors?format=html Christine S. Landry MD, Heather Y. Lin PhD, Alexandria Phan MD, Chusilp Charnsangavej MD, Eddie K. Abdalla MD, J. Nicolas Vauthey MD, James C. Yao MD, Jason B. Fleming MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:06 -0500 C14 – Efficacy of Telotristat Etiprate in Refractory Carcinoid Syndrome: Preliminary Results of a Randomized, Placebo-Controlled, Multicenter Study https://nanets.net/abstracts-archive/2011/131-c14-efficacy-of-telotristat-etiprate-in-refractory-carcinoid-syndrome-preliminary-results-of-a-randomized-placebo-controlled-multicenter-study?format=html C14 – Efficacy of Telotristat Etiprate in Refractory Carcinoid Syndrome: Preliminary Results of a Randomized, Placebo-Controlled, Multicenter Study Matthew H. Kulke, Thomas O'Dorisio, Alexandria Phan, Robert Langdon Jr, Billie Marek, Nadeem Ikhlaque, Emily Bergsland, Joel Freiman, Linda Law, Phillip Banks, Kenny Frazier, Jessica Jackson, Brian Zambrowicz

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/131-c14-efficacy-of-telotristat-etiprate-in-refractory-carcinoid-syndrome-preliminary-results-of-a-randomized-placebo-controlled-multicenter-study?format=html Matthew H. Kulke, Thomas O'Dorisio, Alexandria Phan, Robert Langdon Jr, Billie Marek, Nadeem Ikhlaque, Emily Bergsland, Joel Freiman, Linda Law, Phillip Banks, Kenny Frazier, Jessica Jackson, Brian Zambrowicz

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:05 -0500 C13 – Hepatic Artery Radioembolization (HARE) in the Management of Progressive Metastatic Neuroendocrine Tumors (NETs): A Survival and Biochemical Response Analysis in Geriatric (G) and Young (Y) Populations https://nanets.net/abstracts-archive/2011/130-c13-hepatic-artery-radioembolization-hare-in-the-management-of-progressive-metastatic-neuroendocrine-tumors-nets-a-survival-and-biochemical-response-analysis-in-geriatric-g-and-young-y-populations?format=html C13 – Hepatic Artery Radioembolization (HARE) in the Management of Progressive Metastatic Neuroendocrine Tumors (NETs): A Survival and Biochemical Response Analysis in Geriatric (G) and Young (Y) Populations Khawaja Saad Jahangir, MD, Ryan Majoria, MD, Joe Hagan, PhD, Philip Boudreaux, MD, Yi-Zarn Wang, MD, Brian Boulmay, MD, Richard Campeau, MD, Eugene Woltering, MD, Lowell Anthony, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2011/130-c13-hepatic-artery-radioembolization-hare-in-the-management-of-progressive-metastatic-neuroendocrine-tumors-nets-a-survival-and-biochemical-response-analysis-in-geriatric-g-and-young-y-populations?format=html Khawaja Saad Jahangir, MD, Ryan Majoria, MD, Joe Hagan, PhD, Philip Boudreaux, MD, Yi-Zarn Wang, MD, Brian Boulmay, MD, Richard Campeau, MD, Eugene Woltering, MD, Lowell Anthony, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2011 Thu, 15 Feb 2018 11:53:04 -0500